About CellaVision

Company Description

CellaVision is an innovative, global medical technology company that develops and sells systems for routine analysis of blood and other body fluids in health care services. The products replace manual laboratory work, and support effective workflows and skills development within and between hospitals.

The company has expertise in image analysis, artificial intelligence and automated microscopy. Sales are via global distributors, with support from the parent company in Lund and by the market support organizations in the US, Canada, China, Sweden, Japan, United Arab Emirates, South Korea, Australia, France, Germany, Brazil, Great Britain, Mexico, India, Thailand, Spain, Italy, and Russia. In 2020, sales were SEK 471.4 million. CellaVision's registered office is in Lund, Sweden. The share is listed on the Nasdaq Stockholm, Mid Cap list.

Year founded

1994

Served area

Worldwide

Headquarters

Mobilvägen 12, 22362 Lund – Sweden

Shareholder information

Shares outstanding

24,588,717

IPO

Jan. 1, 2018

Stock exchange(s)

Nasdaq Stockholm

Contact

Newsletter

Subscribe to our newsletter and receive information about recent IPOs, news in the European capital market and more.